Dimeric disulfide form of pantetheine, the immediate CoA precursor (one step from CoA vs. three from pantothenic acid). Proposed dyslipidemia mechanism is inhibition of HMG-CoA reductase and acyl-CoA:cholesterol acyltransferase (ACAT) at the pantetheine stage.
Half-Life (t½)
PO: 0.067h
Dosing Guidelines
PO: Typical 500 mg (Range: 300–900 mg)
Target Organ Systems
cardiovascular
Interactions
Pantothenic acid (B5) (synergistic): Both feed the CoA pool; pantethine is closer to CoA, pantothenate is cheaper. No need to co-supplement.